Description

Salofalk (mesalazine) gastroresistant granules 3 g. №50

Ingredients

Active ingredient: Mesalazine.
Other ingredients: Gastroresistant granules, ethylcellulose, methacrylic acid-ethyl acrylate copolymer, talc, triethyl citrate, and povidone.

Dosage

Recommended dosage: The usual dose is 1-4 g daily in divided doses. Consult your healthcare provider for the appropriate dosage for your condition.

Indications

Salofalk granules are indicated for the treatment of mild to moderate ulcerative colitis and maintenance of remission.

Contraindications

Do not use Salofalk granules if you are allergic to mesalazine or any of the ingredients. Consult your doctor before use if you have kidney or liver problems.

Directions

Take Salofalk granules exactly as prescribed by your healthcare provider. Swallow the granules whole with water. Do not crush or chew them.

Scientific Evidence

Salofalk (mesalazine) has been extensively studied for its efficacy in treating ulcerative colitis. Research published in the “Journal of Crohn’s and Colitis” demonstrated that mesalazine is effective in inducing and maintaining remission in patients with ulcerative colitis.

Additional Information

Salofalk granules work by reducing inflammation in the colon. They are designed to release mesalazine in the lower gastrointestinal tract, targeting the site of inflammation directly. Clinical trials have shown that mesalazine is well-tolerated and effective in reducing symptoms of ulcerative colitis.

Overall, Salofalk (mesalazine) gastroresistant granules 3 g. №50 offer a targeted approach to managing ulcerative colitis with proven efficacy and safety profiles. Consult your healthcare provider for personalized treatment recommendations based on your medical history and condition.